The FDA just made a landmark move in sun protection science. Bemotrizinol has been officially approved as a new sunscreen filter under the FDA's Over-the-Counter Monograph M020 — marking the first new sunscreen active added to the US OTC framework in over 20 years, and one of the most significant updates to sunscreen regulation in decades.
But if you're already using ZÉNUÉ Ultradefence SPF 50 PA++++, here's something worth knowing: you've been protected by this very ingredient all along.
What Is Bemotrizinol?
Bemotrizinol — also known by its trade name Tinosorb S — is a next-generation broad-spectrum UV filter that absorbs and reflects both UVA and UVB radiation. Unlike older UV filters, Bemotrizinol is:
- Photostable — it doesn't degrade in sunlight, meaning your protection stays consistent throughout the day
- Broad-spectrum — it covers both short-wave UVB (responsible for sunburn) and long-wave UVA (responsible for ageing and deeper skin damage)
- Non-sensitising — well-tolerated even by sensitive skin types
- Leaves no white cast — making it ideal for all skin tones, including deeper Indian skin tones
Tinosorb S (Bemotrizinol) has been widely used in European and Asian sunscreens for over two decades. The FDA's approval under Monograph M020 now formally recognises what global dermatology has known for years: this is one of the most effective UV filters available.
Why the FDA’s New Sunscreen Filter Approval Matters
The US has historically lagged behind Europe and Asia in approving advanced UV filters. For years, dermatologists and skincare experts have advocated for the inclusion of newer, more effective filters like Bemotrizinol into the US regulatory framework.
This FDA-approved new sunscreen filter signals a shift toward science-first sun protection — prioritising efficacy, photostability, and skin compatibility over legacy formulation constraints. For Indian consumers already using globally advanced formulations, this is simply official confirmation of what the science has always supported.
ZÉNUÉ Ultradefence: Formulated with Bemotrizinol (Tinosorb S) from Day One
ZÉNUÉ Ultradefence SPF 50 PA++++ was built on the same science the FDA has now validated. Our formula features Tinosorb S (Bemotrizinol) at 4% — working alongside Uvinul A Plus for comprehensive UVA I protection — to deliver a photostable, broad-spectrum shield that performs in real Indian conditions: heat, humidity, pollution, and prolonged sun exposure.
This isn't a reformulation. This isn't a trend we're catching up to. Ultradefence was already there.
What Ultradefence Delivers:
- ☀️ SPF 50 PA++++ — clinically tested broad-spectrum protection
- 🔵 83.55% Blue Light Protection — powered by Lutein (5%)
- 🌫️ Anti-Pollution Shield — with Pollustop (PA Pollution Defence)
- 💧 Hydration + Barrier Support — Hyaluronic Acid, Olive Squalane, Niacinamide (5%)
- 🌿 10+ Botanical Actives — Green Tea, Spirulina, Cucumber, Cactus Flower
- ✨ Velvet-matte, no white cast finish — formulated for Indian skin tones
The Bottom Line
The FDA's recognition of Bemotrizinol as a new sunscreen filter is a win for everyone who takes sun protection seriously. It validates what advanced sunscreen science has long established — and what ZÉNUÉ Ultradefence has been delivering to Indian skin since launch.
If you haven't made Ultradefence part of your daily AM routine, now is the time.
Shop ZÉNUÉ Ultradefence SPF 50 PA++++
Frequently Asked Questions
What is Bemotrizinol?
Bemotrizinol, also known as Tinosorb S, is a next-generation broad-spectrum UV filter that absorbs and reflects both UVA and UVB radiation. It is photostable, non-sensitising, and leaves no white cast — making it one of the most advanced sunscreen actives available.
Is Bemotrizinol the same as Tinosorb S?
Yes. Tinosorb S is the trade name for Bemotrizinol. They refer to the same UV filter — Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine — which is used in premium sunscreens across Europe, Asia, and now formally recognised in the US.
Why is the FDA addition of Bemotrizinol significant?
It is the first new sunscreen filter added to the FDA OTC sunscreen framework in over 20 years. This marks a major shift in US sun protection regulation, finally aligning with the advanced UV filters that European and Asian markets have used for decades.
Is Bemotrizinol FDA approved?
Yes. Bemotrizinol has been officially added as a permitted sunscreen active ingredient under the FDA's Over-the-Counter Monograph M020, marking a significant update to US sunscreen regulation.
Does ZÉNUÉ Ultradefence contain Bemotrizinol?
Yes. ZÉNUÉ Ultradefence SPF 50 PA++++ contains Tinosorb S (Bemotrizinol) at 4%, making it one of the few sunscreens in India formulated with this FDA-approved new sunscreen filter.
What makes Bemotrizinol better than older UV filters?
Bemotrizinol is photostable (doesn't degrade in sunlight), provides broad-spectrum UVA and UVB coverage, is well-tolerated by sensitive skin, and leaves no white cast — making it superior to many older chemical and mineral filters.
Is Bemotrizinol safe for Indian skin?
Absolutely. Bemotrizinol is non-sensitising and has been used safely in European and Asian sunscreens for over two decades. ZÉNUÉ Ultradefence is specifically formulated for Indian skin tones and urban conditions.
Can I use ZÉNUÉ Ultradefence every day?
Yes. Ultradefence is designed for daily use as the last step in your AM skincare routine. Apply generously 15 minutes before sun exposure and reapply every 2–3 hours, especially after sweating or towel drying.
Always apply sunscreen as the last step in your AM routine. Reapply every 2–3 hours, especially after sweating or towel drying.